The segment spotlighted the Baylor-led research recently published in Nature Medicine evaluating autologous Multi-Antigen Targeted T cell therapy in patients with pancreatic ductal adenocarcinoma ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Low Risk Stocks for a Retirement Stock Portfolio. Janux ...

Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...

VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging ...

Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

Scientists at the National Taiwan University Cancer Center and National Taiwan University Hospital have shed light on rare ...

Brazilian researchers have found that stellate pancreatic cells produce periostin, which reshapes surrounding tissue and allows tumors to spread more easily, helping explain why the disease is so ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.